DLK2 and breast carcinoma: Furthermore, our data show that the level of activation of NOTCH and the degree of phosphorylation of the kinases studied in this work, which appear to be modulated by the expression levels of DLK2, may lead to opposite effects on the features of MDA-MB-231 breast cancer cells.